SPP1 and pancreatic neoplasm: At a cutoff of 334 ng/mL, osteopontin achieves 97% specificity and 80% sensitivity for diagnosing resectable pancreatic cancer, with sensitivity comparable to CA19-9 at its respective cutoff (37 U/mL) [93].